Stock Research for gblx

gblx

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

gblx Stock Chart & Research Data

The gblx chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the gblx chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


gblx Due diligence Resources & Stock Charts

The gblx stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View gblx Detailed Price Forecast - CNN Money CNN View gblx Detailed Summary - Google Finance
Yahoo View gblx Detailed Summary - Yahoo! Finance Zacks View gblx Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View gblx Trends & Analysis - Trade-Ideas Barrons View gblx Major Holders - Barrons
NASDAQ View gblx Call Transcripts - NASDAQ Seeking View gblx Breaking News & Analysis - Seeking Alpha
Spotlight View gblx Annual Report - CompanySpotlight.com OTC Report View gblx OTC Short Report - OTCShortReport.com
TradeKing View gblx Fundamentals - TradeKing Charts View gblx SEC Filings - Bar Chart
WSJ View Historical Prices for gblx - The WSJ Morningstar View Performance/Total Return for gblx - Morningstar
MarketWatch View the Analyst Estimates for gblx - MarketWatch CNBC View the Earnings History for gblx - CNBC
StockMarketWatch View the gblx Earnings - StockMarketWatch MacroAxis View gblx Buy or Sell Recommendations - MacroAxis
Bullish View the gblx Bullish Patterns - American Bulls Short Pains View gblx Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View gblx Stock Mentions - StockTwits PennyStocks View gblx Stock Mentions - PennyStockTweets
Twitter View gblx Stock Mentions - Twitter Invest Hub View gblx Investment Forum News - Investor Hub
Yahoo View gblx Stock Mentions - Yahoo! Message Board Seeking Alpha View gblx Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for gblx - SECform4.com Insider Cow View Insider Transactions for gblx - Insider Cow
CNBC View gblx Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for gblx - OTC Markets
Yahoo View Insider Transactions for gblx - Yahoo! Finance NASDAQ View Institutional Holdings for gblx - NASDAQ


Stock Charts

FinViz View gblx Stock Insight & Charts - FinViz.com StockCharts View gblx Investment Charts - StockCharts.com
BarChart View gblx Stock Overview & Charts - BarChart Trading View View gblx User Generated Charts - Trading View




Latest Financial News for gblx


GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations
Posted on Friday December 20, 2019

GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations were able to reduce behavioral changes associated with the loss of dopamine-producing neurons, which underlies the pathology of Parkinson's disease in the animal model. Our final phase of testing will study the mechanism of action for these promising formulations, which could potentially help patients with this debilitating disease. The combined direct and indirect costs associated with Parkinson's disease are estimated at $52 billion in the U.S. alone.


GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain
Posted on Thursday December 05, 2019

LAS VEGAS , Dec. 5, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) announced the execution of a Binding Letter of Intent for the Sale of 75% of its membership interests in the Company's Las Vegas, Nevada cultivation and production operation. This transaction will significantly reduce the Company's operating expenses, generate near-term working capital, and provide ongoing cashflow to enable the Company to focus solely on its biopharmaceutical and wellness assets. The transaction is the next step in the Company's exit from cannabis cultivation and production.


GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement
Posted on Monday November 18, 2019

The Sale, Which Immediately Eliminates Substantial Cash Obligations and Operating Expenses, Is Collateralized by Wellcana Plus's Interest in GB Sciences Louisiana. LAS VEGAS, Nov. 18, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX) completed the sale on November 15, 2019 of its 50% membership interest in GB Sciences Louisiana, LLC to Wellcana Plus, LLC, an affiliate of Wellcana Group, LLC who owns the other 50% interest. The sale immediately eliminates current cash obligations due from GB Sciences as well as the Company's share of operating expenses going forward.


GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
Posted on Wednesday October 09, 2019

LAS VEGAS , Oct. 9, 2019 /CNW/ -- GB Sciences, Inc. (GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. Dr. Andrea Small-Howard , GB Sciences' Chief Science Officer and Director, explains why GB Sciences is well-positioned to provide research-supported product formulations for both market segments.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.